BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| fruit/legume fibre - Erysipelotrichaceae incertae sedis |
👶
Berry-Enriched Diet in Salt-Sensitive Hypertensive Rats: Metabolic Fate of (Poly)Phenols and the Role of Gut Microbiota. Nutrients (Nutrients ) Vol: 11 Issue 11 Pages: Pub: 2019 Nov 3 Epub: 2019 Nov 3 Authors Gomes A , Oudot C , Macià A , Foito A , Carregosa D , Stewart D , Van de Wiele T , Berry D , Motilva MJ , Brenner C , Dos Santos CN , Html Article Publication |
| fruit/legume fibre - Erysipelotrichaceae incertae sedis |
👶
Rebalancing of the gut flora and microbial metabolism is responsible for the anti-arthritis effect of kaempferol. Acta pharmacologica Sinica (Acta Pharmacol Sin ) Vol: 41 Issue 1 Pages: 73-81 Pub: 2020 Jan Epub: 2019 Aug 19 Authors Aa LX , Fei F , Qi Q , Sun RB , Gu SH , Di ZZ , Aa JY , Wang GJ , Liu CX , Html Article Publication |
| fruit/legume fibre - Erysipelotrichaceae incertae sedis |
👶
Curated database of commensal, symbiotic and pathogenic microbiota Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , Publication |
| fruit/legume fibre - Erysipelotrichaceae incertae sedis |
👶
Long-term Consumption of 2-O-?-D-Glucopyranosyl-L-ascorbic Acid from the Fruits of Lycium barbarum Modulates Gut Microbiota in C57BL/6 Micee. Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: Issue Pages: Pub: 2020 Jul 24 Epub: 2020 Jul 24 Authors Dong W , Huang K , Yan Y , Wan P , Peng Y , Zeng X , Cao Y , Publication Publication |
| fruit/legume fibre - Erysipelotrichaceae incertae sedis |
👶
Effect of banana pulp dietary fibers on metabolic syndrome and gut microbiota diversity in high-fat diet mice. Journal of food biochemistry (J Food Biochem ) Vol: Issue Pages: e13362 Pub: 2020 Jul 14 Epub: 2020 Jul 14 Authors Wei G , Ye Y , Yan X , Chao X , Yang F , Wang M , Zhang W , Yuan C , Zeng Q , Publication Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
